FDA Inspection 1014353 — CardioCommand, Inc.

CardioCommand, Inc. — FEI 1927197

The FDA completed an inspection of CardioCommand, Inc. on May 17, 2017 in Tampa, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
May 17, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Tampa, FL (United States)

Citations

IDCFRDescription
313021 CFR 820.100(a)Lack of or inadequate procedures
63021 CFR 803.17Lack of Written MDR Procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.